Endpoints News· Elizabeth Cairns·· 4 小时前AI 评分55
AstraZeneca 追随 GSK 推进每年 15 亿美元成本节约
AstraZeneca follows GSK with $1.5B annual savings push
AI 导读
AstraZeneca 启动成本削减，目标是每年节省 15 亿美元，此前公司后期临床试验受挫，同时还要实现 2030 年 800 亿美元的营收目标。报道称，这一做法与 GSK 此前的节约举措相呼应。
正文 · 原文
October 30, 2026 05:49 AM EDTUpdated 06:14 AM
AstraZeneca follows GSK with $1.5B annual savings push
Battered by late-stage trial failures and determined to meet its ambitious $80 billion-by-2030 revenue goal, AstraZeneca is cutting costs.
…
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源：Endpoints News · endpoints.news